Close Menu

NEW YORK ─ The US Food and Drug Administration in September granted relatively few 510(k) clearances for in vitro diagnostic products as it continued to prioritize Emergency Use Authorizations for the coronavirus pandemic.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.